Autism Spectrum Disorder | NuLife Ventures

AVACEN Autism Spectrum Disorder (ASD) Fever Effect Pilot Study Completed

Little Girl Uses AVACEN Partners NuLife Ventures, LLC and AVACEN Medical, Inc. (AVACEN) have announced the completion of their first research focused on AVACEN therapy and its affect on individuals and families impacted by Autism Spectrum Disorder (ASD). The study, a multi phase (6 weeks per share), sponsored and independent endeavor, completed a 12-family, double blinde, double placebo controlled…

Copyright © 2014-2021 NuLife Ventures LLC. All rights reserved.
The statements (appearing on this website) have not been evaluated by the Food and Drug Administration. NuLife products are not intended to diagnose, treat, cure, or prevent any disease. If you are pregnant, nursing, on medication, have a medical condition, or beginning a weight control system, consult your physician before using NuLife products. *The testimonials presented apply only to the individuals depicted, cannot be guaranteed, and should not be considered typical.

sitemap

English